Couldn't find better thread for this so feel free to move if needed.
Inside China’s ‘Youth-Blood’ Economy: The Anti-Aging Industry Kept in the Shadows
A protest reenacts scenes of forced organ harvesting for profit as China's "default consent" policy causes controversy. (Image: Mandy Cheng/AFP via Getty Images)
By Chen Jing, Vision Times
China’s anti-aging world has long been whispered about — rumors of elite-only clinics, mysterious transfusions, and technologies that blur the line between medicine and taboo. But in recent months, a series of startling public claims, sudden celebrity “rejuvenations,” and viral videos featuring businesswoman Yu Wenhong have forced those whispers into the limelight.
What was once dismissed as fringe speculation is now prompting serious questions about the existence of a multi-million-dollar “youth-blood” industry operating in China’s legal gray zones — and who might be benefiting from it.
I. Why are China’s celebrities suddenly looking younger?
The discussion began when Jet Li posted a hospital-bed photo in August, joking that “the hardware malfunctioned and needed a factory repair.” Weeks later, the 61-year-old resurfaced looking dramatically younger—energetic, toned, and almost unrecognizable. Similar transformations among Hong Jinbao and Ni Ping intensified speculation across Chinese social media about organ replacements, regenerative medicine, and even more experimental biological interventions.
Much of that speculation converged on a single figure: Yu Wenhong, a businesswoman who openly promotes what she calls “youth blood” therapy — an unregulated and ethically murky practice that has thrust China’s underground anti-aging economy into nationwide focus.
II. A businesswoman steps into the spotlight
In recent months, promotional videos linked to Yu circulated widely. Her claims were startling: an anti-aging treatment based on “youth blood,” priced from 1.5 million to 20 million yuan (USD $210,000–$2.8 million) per session.
In one viral clip, Yu compared her technology to the infamous “Lolita Island” rumor: “Have you heard of Lolita Island? Our technology is basically similar to theirs. But theirs is illegal — we are not illegal.” She added, “This is not allowed in the United States because it’s a democratic country. They don’t permit it. In China, it’s not illegal. In an authoritarian society, the Party can decide a person’s life and death.”
Yu insisted her operation was fully legitimate — claiming she ran a large organization, partnered with a publicly listed blood-products company, and possessed official approvals. She further asserted that major shareholders included Robert Kuok via “Pan Pacific Group” and Haier Group.
III. What the law says
Despite Yu’s insistence on legality, Chinese law does not authorize:
The extraction or commercial sale of blood products for rejuvenation,
Anti-aging transfusions,
The harvesting of “microvesicles” from specific demographic groups.
Blood-products companies are licensed to produce plasma-derived pharmaceuticals—not anti-aging infusions. Critics argue that Yu’s operation reframes an ethically prohibited practice as a commercial service that exists only through loopholes and regulatory gray zones.
IV. Blood from “17–21-year-old boys’
Yu’s description of her donor pool triggered widespread alarm. She claimed that “Inside our factory, there are boys aged 17 to 21. Only they have the young functional proteins and microvesicles.” She added, “Anyone under 17 is a minor — we never use their blood.”
Critics immediately noted the implication: if 17–21-year-olds are considered “effective,” then younger donors could be as well, raising disturbing questions about exploitation and coercion. Yu further explained that each individual provides only a small amount: “You need many, many people together before there’s enough for one person. It’s not drawing blood and using it directly—it has to be extracted.”
Extraction still requires large volumes of blood. She also described her own results: “I replace my blood every month. One session costs 1.5 million to 20 million yuan. I’m 55 and still menstruating. I can extend my period until I’m 80.”
V. Longevity politics: A reported conversation with Vladimir Putin
Online accounts have circulated a conversation allegedly exchanged between Chinese leader Xi Jinping and Russian President Vladimir Putin during China’s military parade on Sept. 3. Xi’s interpreter reportdly was heard telling Putin: “In the past, people rarely reached 70; now people say 70 is still a child.”
To which Putin responded with: “With advances in biotechnology, organs can be continually replaced. People may grow younger, even achieve immortality.” Xi then added, “Some predict humans may live to 150 this century.”
If true, the hot mic moment suggests world leaders are openly discussing extreme-longevity technologies, further fueling speculation that China views biotechnology as both a strategic priority and potential geopolitical bargaining chip.
VI. Fetal cells and China’s regenerative industry
Separate attention has turned toward China’s long-standing research into fetal cells. On June 28, 2015, state mouthpiece “People’s Daily” published a controversial article titled: “Mothers with Fetal Microchimerism Are Better Suited to Provide Hematopoietic Stem Cells.”
Critics argue the article signaled deeper institutional interest in the regenerative potential of fetal cells—a field some commentators say has quietly supported the longevity of senior CCP officials for more than a decade. Which then raises another crucial question: Is Yu Wenhong’s “youth microvesicle” technology actually derived from fetal-cell materials?
VII. Three possible intersections with the fetal-cell supply chain
Observers outline three speculative but widely discussed possibilities:
The “microvesicles” are actually fetal-cell exosomes
Medical specialists note that fetal exosomes:
Have the strongest regenerative capability,
Are far cheaper than sourcing blood from young males,
Can be produced at scale.
If true, “youth blood” could be a cover for a fetal-cell–based product.
Yu’s supply may come from cord-blood banks or blood-products companies.
Yu once claimed: “I bought a blood-products company worth over 100 billion yuan,” adding, “Only that company is authorized to purchase blood sources, and it has Ministry of Health approval.”
If accurate, the operation could be embedded within China’s broader fetal-cell and cord-blood industry.
Yu may be a commercial front for a state-backed biotech system.
In this scenario:
Yu is the public face,
research institutes develop the technology,
and state-linked companies manage procurement and distribution.
China’s semi-legal stem-cell sector has long operated through similar hybrid networks.
VIII. The hidden dangers of fetal-cell anti-aging
Fetal-cell therapies are associated with severe risks, including:
Uncontrolled proliferation,
Immune disruption,
Permanent “microchimerism,”
Cancer formation,
And even unpredictable mutations.
The effects may appear rejuvenating (briefly) but could be fatal in the long term. Critics warn that wealthy clients are becoming involuntary test subjects inside a quasi-legal biological marketplace, while ordinary citizens may unknowingly be drawn into supply chains that rely on vulnerable populations.
IX. A disturbing enterprise built on human bodies
The questions surrounding Yu Wenhong’s technology remain unresolved:
What exactly is being infused?
Who provides the biological material?
How deep does this supply chain run within China’s biotech sphere?
Without transparency, observers warn, any “youth therapy” becomes a dark enterprise built on human bodies — turning lives into raw material and catering to the ultra-wealthy in a system where ethics can be rewritten, blurred, or ignored entirely.
Editor’s note: The findings, claims, and timelines referenced in this article are based on publicly available online accounts, citizen-led investigations, and social-media materials that have not been independently verified. They are presented here for informational purposes only.
https://www.visiontimes.com/2025/11/...e-shadows.html





Reply With Quote

Bookmarks